Allarity Therapeutics A/S MDIPF:Grey Market

RT Quote | Exchange | USD
Last | EST
UNCH (UNCH)
52 week range
1.46 - 1.46

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High1.46
  • 52 Week High Date12/01/17
  • 52 Week Low1.46
  • 52 Week Low Date12/01/17
  • Market Cap21.94M
  • Shares Out198.74M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.22
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Allarity Therapeutics A/S News

There is no recent news for this security.

Latest MDIPF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Allarity Therapeutics A/S, formerly known as ONCOLOGY VENTURE A/S, is a Danmark-based company engaged in the development of anticancer medicines. The Company s current priority program focus is on the advancement of three precision medicine treatments: 2X-121, Dovitinib and Ixempra targeting the market for the treatment of ovarian cancer, breast cancer, and renal cell carcinoma.
Duncan Moore Ph.D.
Chairman
Frank Knudsen
Vice Chairman
Steve Carchedi
Chief Executive Officer
Jens Knudsen
Chief Financial Officer
Thomas Jensen
Chief Technology Officer
Claus Deichgraeber
Vice President
Address
Venlighedsvej 1
Hoersholm
2970
Denmark